Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study-Reference-Cited by-同舟云学术

Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study

Published:2019-07 Issue:31 Volume:37 Page:4275-4280
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Zaman Khalequ,Kingma Robert,Yunus Md,van Straaten Ineke,Mekkes Dirk,Bouwstra Xandra,Gunale Bhagwat,Kulkarni Prasad S.

Funder

Bithoven Biologicals, Netherlands

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Poliomyelitis. https://www.who.int/news-room/fact-sheets/detail/poliomyelitis [accessed on 08 June 2019].

2. Poliomyelitis. https://www.who.int/ith/vaccines/polio/en/ [accessed on 24 November 2018].

3. Considerations for the full global withdrawal of oral polio vaccine after eradication of polio;Hampton;J Infect Dis,2017

4. Rationale and timelines for OPV withdrawal. http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/planning/en/ [accessed on 24 November 2018].

5. SAGE confirms global polio vaccine switch date as April 2016. http://polioeradication.org/news-post/sage-confirms-global-polio-vaccine-switch-date-as-april-2016/ [accessed on 24 November 2018].

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial;The Lancet Global Health;2024-05

2. Safety, Immunogenicity and Lot-to-Lot Consistency of a Simplified, Whole Cell, Oral Cholera Vaccines (Euvichol-S) in Nepal: A Phase 3, Observer-Blinded, Randomized, Active-Controlled Trial;2023

3. Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study;The Journal of Infectious Diseases;2020-12-22

4. Corrigendum to “Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study” [Vaccine 37 (2019) 4275–4280];Vaccine;2020-01